SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Remedium Lifecare - Quaterly Results

04 Nov 2022 Evaluate
The sales moved up 31.69% to Rs. 1584.52 millions for the September 2022 quarter as compared to Rs. 1203.23 millions during the year-ago period.Profit after tax for the quarter ended September 2022 reported a huge growth of 98.46% to Rs. 21.89  millions from Rs. 11.03 millions.The company reported a good operating profit of 37.16 millions compared to 11.21 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1584.52 1203.23 31.69 2577.79 2584.54 -0.26 5047.92 900.34 460.67
Other Income 15.72 0.00 0.00 15.72 0.00 0.00 0.00 0.02 -100.00
PBIDT 37.16 11.21 231.49 103.26 15.89 549.84 17.06 7.13 139.27
Interest 0.03 0.00 0.00 0.05 0.00 0.00 1.07 0.00 0.00
PBDT 22.02 11.21 96.43 88.10 15.89 454.44 15.99 7.13 124.26
Depreciation 0.13 0.18 -27.78 1.25 0.34 267.65 0.74 0.60 23.33
PBT 21.89 11.03 98.46 86.85 15.55 458.52 15.25 6.53 133.54
TAX 0.00 0.00 0.00 0.00 0.00 0.00 4.47 1.73 158.38
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 0.00 0.00
PAT 21.89 11.03 98.46 86.85 15.55 458.52 10.78 4.80 124.58
Equity 36.00 36.00 0.00 36.00 36.00 0.00 36.00 36.00 0.00
PBIDTM(%) 2.35 0.93 151.71 4.01 0.61 551.56 0.34 0.79 -57.32

Supha Pharmachem Share Price

0.29 -0.01 (-3.33%)
11-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 231.05
Amrapali Industries 33.42
Adani Enterprises 2908.15
Rashi Peripheral 529.75
PDS 299.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: